Christina König

Christina König is a researcher affiliated with the University of Hamburg's Medical Faculty. Her work focuses on clinical pharmacology, particularly antibiotic pharmacokinetics, drug interactions in critically ill patients, and antimicrobial resistance. She contributes to developing national guidelines, such as the German guideline for invasive pulmonary aspergillosis treatment. Her research addresses challenges in optimizing antibiotic dosing in specialized settings like intensive care units and extracorporeal membrane oxygenation (ECMO). She investigates drug behavior during renal replacement therapies and advanced organ support systems, ensuring effective antimicrobial delivery despite physiological stressors. König also explores drug-drug interactions, particularly in complex cases like severe infections and coronavirus disease (COVID-19) management. Her studies often involve collaborative, multi-center analyses and translational approaches to bridge pharmacology with clinical practice.

Her research spans infectious diseases, including drug-resistant tuberculosis and fungal infections, alongside neurology-related infections like ventriculitis. She emphasizes therapeutic drug monitoring (TDM) for optimizing antibiotic efficacy and minimizing toxicity. König’s work has practical implications for improving patient outcomes in critical care and reducing antimicrobial resistance through precise dosing strategies. She collaborates with pharmacists and clinicians to enhance medication safety and evidence-based practices in acute care settings.